Diclofenac Injection Dosing for Adults
For acute pain management in adults, administer diclofenac 75 mg intramuscularly as a single dose, which can be repeated every 12-24 hours if needed, with a maximum daily dose of 150 mg (two 75 mg injections). For intravenous administration, give 75 mg as a slow bolus over 5-30 seconds or as an infusion over 30 minutes, repeated every 12-24 hours as needed 1.
Route-Specific Dosing
Intramuscular Administration
- Standard dose: 75 mg as a single deep IM injection 1
- Frequency: Can repeat after 12-24 hours if pain persists
- Maximum daily dose: 150 mg (two 75 mg doses) 2, 3, 2
- Duration: Use for shortest duration necessary, typically 1-2 days for acute pain 4
The 75 mg IM dose provides rapid analgesia with peak effect within 30 minutes and demonstrates superior early pain relief compared to oral formulations 4.
Intravenous Administration
- Standard dose: 75 mg IV 5, 6
- Administration methods:
- Frequency: Every 6-12 hours as needed
- Maximum daily dose: 150 mg 1
Important: Intramuscular injections have no pharmacokinetic advantage over IV route and are more painful 2. Newer formulations allow rapid IV bolus administration without the need for prolonged infusion 5.
Lower Dose Options
For patients requiring less aggressive analgesia or at higher risk for adverse effects:
- 18.75 mg to 37.5 mg IV every 6 hours has demonstrated efficacy in postoperative pain 6
- 50 mg IM or IV can be used for moderate pain 8
- These lower doses still provide significant pain relief while potentially reducing adverse event risk
Clinical Context
Acute musculoskeletal pain: The 75 mg IM dose achieves 50% pain reduction in approximately 99% of patients within 30 minutes, compared to 87% with oral administration 4. This translates to a number needed to treat of 8 for achieving rapid pain relief with IM versus oral route.
Postoperative pain: Both 18.75 mg and 37.5 mg IV doses every 6 hours significantly reduce pain intensity and opioid requirements compared to placebo 6. The 75 mg dose provides equivalent analgesic exposure to traditional 30-minute infusions but with faster onset 5.
Critical Safety Considerations
Contraindications and Precautions
- Avoid in pregnancy at ≥30 weeks gestation (risk of premature ductus arteriosus closure) 1
- Limit use between 20-30 weeks gestation (risk of oligohydramnios) 1
- Renal impairment: Reduce frequency and monitor closely 2
- Cardiovascular disease: Use lowest effective dose for shortest duration 1
- Gastrointestinal risk: Consider gastroprotection for prolonged use 2
Maximum Duration
- Parenteral diclofenac should be limited to 2 days for acute pain management 2
- Transition to oral NSAIDs if longer treatment needed
- Total treatment duration (parenteral + oral) should not exceed 5-7 days without reassessment
Drug Interactions
- Avoid with other NSAIDs or aspirin (increased GI toxicity without added benefit) 1
- Caution with anticoagulants (increased bleeding risk)
- Monitor with methotrexate (increased toxicity risk) 1
- Avoid 2 days before and after pemetrexed in cancer patients 1
Practical Algorithm
Assess pain severity and route feasibility
- Severe acute pain requiring rapid onset → 75 mg IM or IV bolus
- Moderate pain or postoperative setting → Consider 37.5-75 mg IV
- Oral route feasible and time permits → Consider oral diclofenac instead
Choose administration route
- IV access available → IV bolus (faster, less painful than IM)
- No IV access → IM injection (still provides rapid relief)
Dosing schedule
- Initial dose: 75 mg
- Reassess at 30 minutes (IM) or 15 minutes (IV)
- Repeat dose: After 12-24 hours if needed
- Maximum: 150 mg/day for maximum 2 days
Transition plan
- Switch to oral NSAIDs after 1-2 days if continued treatment needed
- Consider adding acetaminophen for multimodal analgesia
- Avoid exceeding 5-7 days total NSAID therapy
Common pitfall: Do not use intramuscular route simply out of habit—IV administration is less painful and equally effective when IV access is available 2. The newer formulations specifically allow rapid IV bolus, eliminating the historical need for prolonged infusions 5.